Twist Bioscience Corporation

About

Twist Bioscience is a biotechnology company that specializes in synthetic DNA manufacturing. Their proprietary silicon-based platform enables high-throughput DNA synthesis, allowing researchers to access quality tools for various applications, including next-generation sequencing (NGS), gene synthesis, and antibody discovery. The company aims to drive biological innovations that contribute to a safer, healthier, and more sustainable world.

Verified company data

Cash position

$477.9 million

Shares outstanding

61,702

Projects

["Twist Oligo Pools are highly diverse collections of single-stranded oligonucleotides synthesized using our silicon-based DNA writing technology. Our synthesis platform enables massively parallel production of hundreds of thousands of high-quality, accurate oligos per run, allowing the generation of complex and diverse oligo pools for use in applications like CRISPR screening."]

Verified data last updated: 2026-09-25

Recent filings

• Notice of proposed sale of securities pursuant to Rule 1442026-10-01 · twst_2026-10-01_19-27-48.pdf→
• Statement of changes in beneficial ownership of securities2026-09-25 · twst_2026-09-25_19-05-16.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-09-24 · twst_2026-09-24_20-45-27.pdf→
• Statement of changes in beneficial ownership of securities2026-09-23 · twst_2026-09-23_19-08-31.pdf→
• Statement of changes in beneficial ownership of securities2026-09-23 · twst_2026-09-23_19-07-40.pdf→
• Statement of changes in beneficial ownership of securities2026-09-21 · twst_2026-09-21_19-05-13.pdf→
• Notice of proposed sale of securities pursuant to Rule 1442026-09-17 · twst_2026-09-17_19-34-48.pdf→
• Statement of changes in beneficial ownership of securities2026-09-10 · twst_2026-09-10_19-00-08.pdf→